Clopidogrel With Eptifibatide to Arrest the Reactivity of Platelets - CLEAR PLATELETS-2


The goal of the trial was to evaluate platelet reactivity and clot strength following combination therapy with bivalirudin and eptifibatide compared with bivalirudin alone in patients undergoing elective percutaneous coronary intervention (PCI), and to determine whether these variables were related to periprocedural infarction.